These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35859868)

  • 1. Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain.
    Previti S; Ettari R; Calcaterra E; Di Chio C; Ravichandran R; Zimmer C; Hammerschmidt S; Wagner A; Bogacz M; Cosconati S; Schirmeister T; Zappalà M
    ACS Med Chem Lett; 2022 Jul; 13(7):1083-1090. PubMed ID: 35859868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.
    Previti S; Ettari R; Di Chio C; Ravichandran R; Bogacz M; Hellmich UA; Schirmeister T; Cosconati S; Zappalà M
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
    Previti S; Ettari R; Cosconati S; Amendola G; Chouchene K; Wagner A; Hellmich UA; Ulrich K; Krauth-Siegel RL; Wich PR; Schmid I; Schirmeister T; Gut J; Rosenthal PJ; Grasso S; Zappalà M
    J Med Chem; 2017 Aug; 60(16):6911-6923. PubMed ID: 28763614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Cosconati S; Schirmeister T; Zappalà M; Ettari R
    ChemMedChem; 2020 Jun; 15(11):995-1001. PubMed ID: 32329206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense.
    Di Chio C; Previti S; Amendola G; Ravichandran R; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M; Ettari R
    Eur J Med Chem; 2022 Jun; 236():114328. PubMed ID: 35385806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment.
    Maiorana S; Ettari R; Previti S; Amendola G; Wagner A; Cosconati S; Hellmich UA; Schirmeister T; Zappalà M
    ChemMedChem; 2020 Aug; 15(16):1552-1561. PubMed ID: 32567172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins.
    Jung S; Fuchs N; Grathwol C; Hellmich UA; Wagner A; Diehl E; Willmes T; Sotriffer C; Schirmeister T
    Eur J Med Chem; 2022 Aug; 238():114460. PubMed ID: 35597010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.
    Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M
    Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities.
    Zhang H; Collins J; Nyamwihura R; Crown O; Ajayi O; Ogungbe IV
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127217. PubMed ID: 32527539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of tetrahydroisoquinoline derivatives against Trypanosoma brucei rhodesiense.
    Cullen DR; Gallagher A; Duncan CL; Pengon J; Rattanajak R; Chaplin J; Gunosewoyo H; Kamchonwongpaisan S; Payne A; Mocerino M
    Eur J Med Chem; 2021 Dec; 226():113861. PubMed ID: 34624822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of
    Di Chio C; Previti S; De Luca F; Bogacz M; Zimmer C; Wagner A; Schirmeister T; Zappalà M; Ettari R
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Michael acceptor based antiplasmodial and antitrypanosomal cysteine protease inhibitors with unusual amino acids.
    Breuning A; Degel B; Schulz F; Büchold C; Stempka M; Machon U; Heppner S; Gelhaus C; Leippe M; Leyh M; Kisker C; Rath J; Stich A; Gut J; Rosenthal PJ; Schmuck C; Schirmeister T
    J Med Chem; 2010 Mar; 53(5):1951-63. PubMed ID: 20131843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei.
    Schirmeister T; Schmitz J; Jung S; Schmenger T; Krauth-Siegel RL; Gütschow M
    Bioorg Med Chem Lett; 2017 Jan; 27(1):45-50. PubMed ID: 27890381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense.
    Caffrey CR; Hansell E; Lucas KD; Brinen LS; Alvarez Hernandez A; Cheng J; Gwaltney SL; Roush WR; Stierhof YD; Bogyo M; Steverding D; McKerrow JH
    Mol Biochem Parasitol; 2001 Nov; 118(1):61-73. PubMed ID: 11704274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bistacrines as potential antitrypanosomal agents.
    Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
    Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and In Vivo Studies.
    Jung S; Fuchs N; Johe P; Wagner A; Diehl E; Yuliani T; Zimmer C; Barthels F; Zimmermann RA; Klein P; Waigel W; Meyr J; Opatz T; Tenzer S; Distler U; Räder HJ; Kersten C; Engels B; Hellmich UA; Klein J; Schirmeister T
    J Med Chem; 2021 Aug; 64(16):12322-12358. PubMed ID: 34378914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug combination studies of PS-1 and quercetin against rhodesain of
    Di Chio C; Previti S; De Luca F; Allegra A; Zappalà M; Ettari R
    Nat Prod Res; 2022 Aug; 36(16):4282-4286. PubMed ID: 34533390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines.
    Robinson WJ; Taylor AE; Lauga-Cami S; Weaver GW; Arroo RRJ; Kaiser M; Gul S; Kuzikov M; Ellinger B; Singh K; Schirmeister T; Botana A; Eurtivong C; Bhambra AS
    Eur J Med Chem; 2021 Jan; 209():112871. PubMed ID: 33070078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis.
    Ettari R; Previti S; Maiorana S; Amendola G; Wagner A; Cosconati S; Schirmeister T; Hellmich UA; Zappalà M
    J Med Chem; 2019 Dec; 62(23):10617-10629. PubMed ID: 31714776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzimidazole inhibitors of the major cysteine protease of
    Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
    Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.